Synchronous and Antecedent Nonthyroidal Malignancies in Patients with Papillary Thyroid Carcinoma

被引:11
作者
Murray, Sara E. [1 ]
Schneider, David F. [1 ]
Bauer, Philip S. [1 ]
Sippel, Rebecca S. [1 ]
Chen, Herbert [1 ]
机构
[1] Univ Wisconsin, Sect Endocrine Surg, Dept Surg, Madison, WI 53792 USA
基金
美国国家卫生研究院;
关键词
2ND PRIMARY MALIGNANCIES; CANCER INCIDENCE; POOLED ANALYSIS; RISK;
D O I
10.1016/j.jamcollsurg.2013.02.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: There is a known association between the development of papillary thyroid cancer (PTC) after a primary nonthyroidal cancer (NTC). However, the prevalence of synchronous or antecedent NTCs in patients with PTC is undetermined, as are the clinicopathologic characteristics of PTC in these patients. STUDY DESIGN: A review was performed of our prospectively maintained PTC database between January 1995 and December 2010. Information collected included patient and tumor characteristics, medical history, PTC presentation, and treatment modality. RESULTS: Four hundred and thirty-three adult patients underwent thyroid resection and had PTC on final pathology. Sixty-seven cases of synchronous or antecedent NTCs were observed in 60 patients (13.9%). The most commonly associated antecedent NTCs were breast (n = 11), prostate (n = 8), and melanoma (n = 5), whereas renal cell carcinoma (n = 3) and melanoma (n = 3) were the synchronous NTCs most observed. Compared with patients without an NTC, those with an NTC were older (56.4 +/- 15.5 years vs 44.9 +/- 14.2 years; p < 0.0001), had experienced radiation exposure (35.0% vs 3.5%; p < 0.001), and more commonly presented with a thyroid mass incidentally on imaging (41.7% vs 9.1%; p <= 0.001). Papillary thyroid cancer tumor characteristics were similar between groups, except that NTC patients presented at a more advanced stage. However, when analyzed independently, primary tumor size, and nodal and distant metastases were comparable. CONCLUSIONS: The prevalence of synchronous or antecedent NTCs in patients surgically treated for PTC is 13.9%. These patients present with PTC tumor characteristics similar to those without additional NTCs, and should therefore be managed equivalently. In addition, surgeons should be aware of the frequency of synchronous PTC with these types of tumors and consider evaluation of the neck at the time of NTC diagnosis. (J Am Coll Surg 2013; 216: 1174-1180. (C) 2013 by the American College of Surgeons)
引用
收藏
页码:1174 / 1180
页数:7
相关论文
共 25 条
  • [1] Second cancers in survivors of childhood cancer
    Bhatia, S
    Sklar, C
    [J]. NATURE REVIEWS CANCER, 2002, 2 (02) : 124 - +
  • [2] Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study
    Bhatti, Parveen
    Veiga, Lene H. S.
    Ronckers, Cecile M.
    Sigurdson, Alice J.
    Stovall, Marilyn
    Smith, Susan A.
    Weathers, Rita
    Leisenring, Wendy
    Mertens, Ann C.
    Hammond, Sue
    Friedman, Debra L.
    Neglia, Joseph P.
    Meadows, Anna T.
    Donaldson, Sarah S.
    Sklar, Charles A.
    Robison, Leslie L.
    Inskip, Peter D.
    [J]. RADIATION RESEARCH, 2010, 174 (06) : 741 - 752
  • [3] The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
    Brown, Aaron. P.
    Chen, Jergin
    Hitchcock, Ying J.
    Szabo, Aniko
    Shrieve, Dennis C.
    Tward, Jonathan. D.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02) : 504 - 515
  • [4] Risk of second primary malignancies in women with papillary thyroid cancer
    Canchola, AJ
    Horn-Ross, PL
    Purdie, DM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (06) : 521 - 527
  • [5] CRAIL H W, 1949, U S Nav Med Bull, V49, P123
  • [6] CHEK2 is a multiorgan cancer susceptibility gene
    Cybulski, C
    Górski, B
    Huzarski, T
    Masojc, B
    Mierzejewski, M
    Debniak, T
    Teodorczyk, U
    Byrski, T
    Gronwald, J
    Matyjasik, J
    Zlowocka, E
    Lenner, M
    Grabowska, E
    Nej, K
    Castaneda, J
    Medrek, K
    Szymanska, A
    Szymanska, J
    Kurzawski, G
    Suchy, J
    Oszurek, O
    Witek, A
    Narod, SA
    Lubinski, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (06) : 1131 - 1135
  • [7] Increasing incidence of thyroid cancer in the United States, 1973-2002
    Davies, L
    Welch, HG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18): : 2164 - 2167
  • [8] Edge S.B., 2010, AJCC cancer staging manual, V649
  • [9] Will the real Cowden syndrome please stand up: revised diagnostic criteria
    Eng, C
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (11) : 828 - 830
  • [10] A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases
    Franceschi, S
    Preston-Martin, S
    Maso, LD
    Negri, E
    La Vecchia, C
    Mack, WJ
    McTiernan, A
    Kolonel, L
    Mark, SD
    Mabuchi, K
    Jin, F
    Wingren, G
    Galanti, R
    Hallquist, A
    Glattre, E
    Lund, E
    Levi, F
    Linos, D
    Ron, E
    [J]. CANCER CAUSES & CONTROL, 1999, 10 (06) : 583 - 595